BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2459534)

  • 1. Selective suppression of pressor and sympathetic responses to centrally infused TRH in hypothyroid rats.
    Buñag RD; Mattila J
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):51-7. PubMed ID: 2459534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressor and sympathetic responses to dorsal raphe nucleus infusions of TRH in rats.
    Mattila J; Buñag RD
    Am J Physiol; 1990 Jun; 258(6 Pt 2):R1464-71. PubMed ID: 2113776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic vasoconstriction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    J Pharmacol Exp Ther; 1986 Jul; 238(1):232-6. PubMed ID: 3088259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathomimetic pressor responses to thyrotropin-releasing hormone in rats.
    Mattila J; Buñag RD
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H86-92. PubMed ID: 3089031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat.
    Sirén AL; Lake CR; Feuerstein G
    Circ Res; 1988 Jan; 62(1):139-54. PubMed ID: 2891452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotension and hypothalamic depression produced by intracerebroventricular injections of GABA in spontaneously hypertensive rats.
    Sasaki S; Lee LC; Nakamura Y; Iyota I; Fukuyama M; Inoue A; Takeda K; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Nov; 50(11):1140-8. PubMed ID: 3820527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
    Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of the pressor response to intravenous thyrotropin-releasing hormone in the rat.
    Evequoz D; Burnier M; Niederberger M; Brunner HR; Nussberger J; Waeber B
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):93-100. PubMed ID: 8039276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic cerebroventricular infusion of hypertonic sodium chloride in rats reduces hypothalamic sympatho-inhibition and elevates blood pressure.
    Miyajima E; Buñag RD
    Circ Res; 1984 May; 54(5):566-75. PubMed ID: 6723000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic inhibition and vasopressin mediation during centrally induced responses to serotonin in rats.
    Inoue A; Buñag RD
    J Cardiovasc Pharmacol; 1989 Jun; 13(6):902-7. PubMed ID: 2484085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the pressor effect of centrally administered thyrotropin-releasing hormone under halothane, pentobarbital and flunitrazepam anaesthesia.
    Tanaka H; Okuda C; Sawa T; Mizobe T; Demura H; Miyazaki M
    Acta Anaesthesiol Scand; 1988 Oct; 32(7):535-40. PubMed ID: 3142198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modifications of sympathetic responses elicited by hypothalamic stimulation in the rat.
    Morpurgo C
    Br J Pharmacol; 1968 Nov; 34(3):532-42. PubMed ID: 5726784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally inhibitory effect of adrenaline on cardiovascular and sympathetic nerve system in urethane anesthetized rat.
    Takeda K; Okajima H; Takahashi H; Sasaki S; Iyoda I; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1985 Mar; 49(3):311-5. PubMed ID: 3981789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
    Okuda C; Mizobe T; Miyazaki M
    Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of peripheral and central catecholaminergic and cholinergic mechanisms in the cardiovascular effects of thyrotropin-releasing hormone.
    Nurminen ML; Paakkari I
    Neuropeptides; 1991 Dec; 20(4):247-53. PubMed ID: 1667428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic somatostatin mediates the suppression of growth hormone secretion by centrally administered thyrotropin-releasing hormone in conscious rats.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1985 Sep; 117(3):1139-44. PubMed ID: 2862016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone response to thyrotropin-releasing hormone in the urethane-anesthetized rat: effect of thyroid status.
    Szabo M; Ruestow PC; Kramer DE
    Endocrinology; 1985 Jul; 117(1):330-7. PubMed ID: 3924582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects produced by injections of thyrotropin-releasing hormone in specific preoptic and hypothalamic nuclei in the rat.
    Diz DI; Jacobowitz DM
    Peptides; 1984; 5(4):801-8. PubMed ID: 6436799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hypothyroidism on hypothalamic release of thyrotropin-releasing hormone in rats.
    Rondeel JM; de Greef WJ; Klootwijk W; Visser TJ
    Endocrinology; 1992 Feb; 130(2):651-6. PubMed ID: 1733713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro.
    Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA
    Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.